Latest in Version Novo

Sort by

3 items

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
CNBC - 1d
European markets open higher in shortened session ahead of Christmas; Novo Nordisk resumes recovery

European stocks edged higher at the open on Tuesday.
CNBC - 1d
FDA approves generic version of Novo Nordisk's GLP-1 diabetes drug Victoza

The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.
NBC News - 1d

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions